• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biosens Bioelectron . Performance of electrochemical immunoassays for clinical diagnostics of SARS-CoV-2 based on selective nucleocapsid N protein d

tetano

Editor, Senior Moderator
Biosens Bioelectron


. 2022 Apr 8;209:114222.
doi: 10.1016/j.bios.2022.114222. Online ahead of print.
Performance of electrochemical immunoassays for clinical diagnostics of SARS-CoV-2 based on selective nucleocapsid N protein detection: Boron-doped diamond, gold and glassy carbon evaluation


Wioleta Białobrzeska[SUP] 1 [/SUP], Mateusz Ficek[SUP] 2 [/SUP], Bartłomiej Dec[SUP] 2 [/SUP], Silvio Osella[SUP] 3 [/SUP], Bartosz Trzaskowski[SUP] 3 [/SUP], Andres Jaramillo-Botero[SUP] 4 [/SUP], Mattia Pierpaoli[SUP] 2 [/SUP], Michał Rycewicz[SUP] 2 [/SUP], Yanina Dashkevich[SUP] 1 [/SUP], Tomasz Łęga[SUP] 1 [/SUP], Natalia Malinowska[SUP] 1 [/SUP], Zofia Cebula[SUP] 1 [/SUP], Daniel Bigus[SUP] 1 [/SUP], Daniel Firganek[SUP] 1 [/SUP], Ewelina Bięga[SUP] 1 [/SUP], Karolina Dziąbowska[SUP] 5 [/SUP], Mateusz Brodowski[SUP] 6 [/SUP], Marcin Kowalski[SUP] 6 [/SUP], Mirosława Panasiuk[SUP] 7 [/SUP], Beata Gromadzka[SUP] 7 [/SUP], Sabina Żołędowska[SUP] 8 [/SUP], Dawid Nidzworski[SUP] 5 [/SUP], Krzysztof Pyrć[SUP] 9 [/SUP], William A Goddard 3rd[SUP] 4 [/SUP], Robert Bogdanowicz[SUP] 10 [/SUP]



Affiliations

Abstract

The 21st century has already brought us a plethora of new threats related to viruses that emerge in humans after zoonotic transmission or drastically change their geographic distribution or prevalence. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first spotted at the end of 2019 to rapidly spread in southwest Asia and later cause a global pandemic, which paralyzes the world since then. We have designed novel immunosensors targeting conserved protein sequences of the N protein of SARS-CoV-2 based on lab-produced and purified anti-SARS-CoV-2 nucleocapsid antibodies that are densely grafted onto various surfaces (diamond/gold/glassy carbon). Titration of antibodies shows very strong reactions up to 1:72 900 dilution. Next, we showed the mechanism of interactions of our immunoassay with nucleocapsid N protein revealing molecular recognition by impedimetric measurements supported by hybrid modeling results with both density functional theory and molecular dynamics methods. Biosensors allowed for a fast (in less than 10 min) detection of SARS-CoV-2 virus with a limit of detection from 0.227 ng/ml through 0.334 ng/ml to 0.362 ng/ml for glassy carbon, boron-doped diamond, and gold surfaces, respectively. For all tested surfaces, we obtained a wide linear range of concentrations from 4.4 ng/ml to 4.4 pg/ml. Furthermore, our sensor leads to a highly specific response to SARS-CoV-2 clinical samples versus other upper respiratory tract viruses such as influenza, respiratory syncytial virus, or Epstein-Barr virus. All clinical samples were tested simultaneously on biosensors and real-time polymerase chain reactions.
 
Back
Top Bottom